Bordetella bronchiseptica is a clinically significant pathogen for canine infectious respiratory disease (CIRD), otherwise known as kennel cough, with 78.7% of dogs with acute respiratory signs testing positive for the bacteria1.
In the same study, 45.6% of clinically healthy dogs also tested positive for Bordetella bronchiseptica, illustrating that clinically healthy dogs can carry respiratory pathogens and could act as sources of infection for susceptible dogs1.
Administered via subcutaneous injection, Canigen Bb is an inactivated subunit vaccine which offers vets a new option when intra-nasal vaccination with a live aerosolised vaccine is not possible or preferred, for example when the dog is in contact with known immunocompromised individuals.
Licensed for use in dogs from 6 weeks of age, Canigen Bb extends protection against Bordetella bronchiseptica in dogs vaccinated with Canigen KC in the last 12 months for a further year with a single dose.
Canigen Bb is presented as a ready-to-use formula in a 10ml multi-dose bottle and can be stored at room temperature (2°C - 25°C) for up to 4 weeks once broached.
It can be administered concurrently (at the same time but separate injections) with Canigen DHP, Canigen DHPPi, Canigen Pi & Canigen Lepto 4.
Andrew Connolly, Marketing Director at Virbac, said: ‘It is our hope that Canigen Bb will increase the overall uptake of Bordetella bronchiseptica vaccination to provide increased protection against this widely prevalent and clinically significant disease’.
Reference
Zoetis has launched a 4ml vial of the antibiotic, Convenia.
Zoetis says Convenia gives veterinary surgeons control by providing an assured injectable treatment course, relieving clients of the burden of daily dosing. This avoids missed or mistimed doses, lost tablets, or courses stopped too soon, thereby eliminating a major reason for treatment failure, non-compliance. Poor compliance is also a significant factor in the development of antimicrobial resistance.
Convenia is licensed for skin, soft tissue and urinary tract infections in dogs and cats, as well as severe gingivitis/periodontitis in dogs (as an adjunct to mechanical or surgical periodontal therapy). A 4ml vial can treat up to 40kg of bodyweight, making it appropriate for treating cats and smaller dogs.
Zoetis says that the launch of the new vial demonstrates its commitment to the 'Respect Antibiotics' campaign launched last year. The Respect Antibiotics campaign encourages careful and informed selection of appropriate antibiotic therapies for the treatment of dogs and cats.
Product Manager, Andrew Page, said; "We are committed to encouraging responsible antibiotic usage, and reducing the incidence of antibiotic resistance. Non-compliance plays a key role in the development of antibiotic resistance and we hope that by making Convenia more accessible through the introduction of a 4ml vial we can help alleviate compliance issues."
For further details about Convenia please contact your Zoetis Account Manager.
The letter called on the UK government to ensure there is a duty on the state to have due regard for animal welfare in the development and implementation of policy, as Article 13 of the Lisbon Treaty sets out. Under the UK’s Animal Welfare Acts, accountability for the treatment of an animal focuses on the animal keeper, but not on the state.
The coordinated letter from the veterinary professions follows widespread media attention after a House of Commons debate, wherein MPs voted down an amendment tabled by Green MP Caroline Lucas to include the principles set out in Article 13, which also states animals are sentient, in the EU (Withdrawal) Bill. Since Article 13 has its origins in a treaty rather than a regulation, it did not qualify to automatically transfer into UK law as part of the EU (Withdrawal) Bill.
The signatories of the Daily Telegraph letter span all areas of veterinary work including small and large animal practice, research, government and academia as well as including former UK Deputy Chief Veterinary Officers, Officers of BVA specialist divisions and the Chief Veterinary Officer of SSPCA, amongst others.
BVA Senior Vice President Gudrun Ravetz has been leading BVA’s lobbying on this issue while BVA President John Fishwick recovers from a back operation. Gudrun said: "The public and professional response to the Article 13 vote was astonishing, but there was much misunderstanding borne from sensationalist headlines that suggested the MPs who voted the amendment down do not believe in animal sentience. The real crux of the debate got lost in this noise.
"BVA supports the principle of Article 13, since it not only recognises that animals are sentient, but importantly puts a duty on the state to have due regard for animal welfare in the development and implementation of policy."
Alasdair qualified from Cambridge in 1990. After graduation, he joined Bristol Vet School, first as an intern and then as a resident.
He then became a Lecturer and Senior Clinical Fellow in small animal surgery at Langford from 1997 to 2009.
He was also the Programme Director of the veterinary nursing degree and led years 3-5 of the BVSc programme.
He then moved to private practice, becoming Head of Referral Surgery at Bath Vet Referrals, and then Group Veterinary Advisor and member of the Clinical Advisory Board when it was acquired by IVC, after which he moved to Vale Referrals.
He received his Fellowship for Contributions to Clinical Practice in 2017 and is an Advanced Practitioner in Small Animal Surgery.
Alasdair will mainly be helping to develop Brains & Drains, a new library of peer-reviewed clinical demonstrations published on YouTube for the benefit of practitioners around the world.
He’ll also be helping to steer the development of other content on VetSurgeon.org and VetNurse.co.uk
Publishing Editor Arlo Guthrie said: “Alasdair and I first collaborated nine years ago to make a film called: Total Ear Canal Ablation and Lateral Bulla Osteotomy.
"Who’d have that would be such a box office hit, with over 90,000 views on Facebook!
“Now we’re stepping up production, both by filming our own content and inviting all vets and nurses to film demonstrations themselves and submit them for peer review.”
Arlo added: “In recent years, there's been an explosion in the number of social media groups for the veterinary profession, primarily on Facebook and Instagram, which has led to a real fragmentation.
It’s as yet unclear whether that'll always be the case. Certainly young people are already migrating elsewhere, both because it’s not very hip to be on the same platform as your parents, and also a growing awareness of some of the harms of Facebook on mental health."
“Either way, with so much fragmentation, it is clear we need to offer more by way of quality content on VetSurgeon.org than we have in the past, and I’m really excited to be working alongside Alasdair to do just that, so that whatever the ups and downs of other social media, VetSurgeon and VetNurse remain reliable, transparent places for good quality information sharing.”
Bell Equine is one of the leading equine hospitals and was the first practice worldwide to install a standing MRI unit for horses.
CVS says the acquisition reflects its increased focus on equine practice, with further expansion of its Equine Division planned in the UK and Europe during 2017.
Equine Director Ben Jacklin said: "The acquisition of such an outstanding hospital is an exciting step for us. Bell Equine has always been at the forefront of the equine profession, both clinically and non-clinically, and as such it is a perfect match for the Equine Division of CVS."
Julian Samuelson, former managing director of Bell Equine, will continue in the role of Clinical Director. He said: "We are delighted to be joining forces with CVS and are very much looking forward to working closely with the Group to help realise the exciting potential of its equine ambitions. We look forward to the opportunity to continue to lead the profession, both within and outside CVS."
Dermipred is available in two pack sizes – 10mg and 20mg - to treat a range of dog sizes. Both presentations feature a four-way break tablet to enable accurate and flexible dosing, and the product is flavoured to aid compliance. The product is blister-packed for easy dispensing.
Ceva has produced an accompanying electronic brochure on CAD management options. It includes: understanding and decoding CAD, diagnosis and management of the condition.
Allison Henry, Dermipred product manager at Ceva said: "CAD affects approximately a million dogs in the UK, with 70% of all owners believing that the condition has had an impact on their dogs’ quality of life1.
"The addition of Dermipred to Ceva’s extensive dermatology range will provide veterinary professionals with even more treatment options for the management of pruritus and skin inflammation in CAD cases."
To support the launch of Dermipred, Ceva will be running an offer on its dermatology range of products: every client purchasing a box of each Dermipred presentation and a bottle of Modulis will receive one box of Dermipred 10mg, one bottle of the same Modulis size and one bottle of Douxo Calm shampoo and mousse free.
For further information, contact your local Ceva account manager or email cevauk@ceva.com.
The initiative will run until early 2019, and has been expanded to include cats as well as dogs. In the run up, Lintbells is also offering lunch and learn sessions to help practices implement the clinics.
The company reports that feedback from 50 veterinary surgeons, nurses and practice managers who took part in the initiative last year was encouragingly positive. 86% agreed or strongly agreed that they are now managing mobility issues more effectively in practice and 90% thought client compliance had increased.
96% said they thought vets, nurses and reception staff were communicating more effectively. 95% thought the training had improved staff morale. 94% of veterinary staff felt clients were more confident about managing their pet’s condition and 92% thought more mobility issues had been identified. 74% said they thought practice revenue had increased.
Lintbells Brand Manager, Gemma Cunningham said: "We’re really pleased to be able to help practices to provide support for pets with stiff joints. This year we’ve made some exciting additions to the practice pack based on our ongoing conversations and feedback. Mobility issues in cats are often overlooked and we want to raise awareness and help support owners. By including cats this time round we hope to assist practices with their efforts to encourage cat owners to have their less active and sedentary cats checked out."
Practices that want to register an interest in receiving a Mobility Matters pack can contact their local Lintbells Veterinary Business Development Executive or visit www.lintbellsvet.com.
Invicta, the new, independent veterinary pharmaceutical company, has launched ChroMyco Duo, the first duo plate dermatophtye fungal test to help veterinary professionals identify the source of skin abnormalities in-house without the delay and cost of sending samples to a laboratory.
According to the Sussex-based company, ChroMyco Duo has been designed to aid practices in the accurate identification of fungal skin infections in dogs, cats, horses and all small animal species.
ChroMyco Duo is a dual plate test with dermatophyte test media (DTM) on one side and an Enhanced Sporulation Agar (ESA) on the other. Invicta says it's this dual test capability which greatly reduces the risk of false positive results. The test is performed by veterinary staff taking a pluck of fur or skin scrape from the lesion and innoculating both sides. After three to six days, if dermatophytes are present, the DTM will turn red and the ESA will turn blue-green.
Once a colour change is identified, a sample of the culture can be taken from the ESA, a media prolific in growing dermatophytes. Veterinary staff are then able to examine the fungus microscopically and identify the species of dermatophyte before advising on treatment.
Invicta has prepared a free fungal identification chart to assist practices with the identification of cultures and is providing free updates to subscribers, as images of new fungi are submitted by practices using the kit.
The ChroMyco Duo test is supplied in boxes of five units, each individually wrapped to allow a one year shelf life. It costs £5 per unit, which Invicta says makes it very cost-effective when compared to laboratory charges. It is incubated at room temperature so no specialist equipment is required.
Rob Watkins, Managing Director of Invicta, said: "The incidence of fungal infections in practice is significant and growing. Antifungal treatments already account for more than £1m sales in the UK veterinary sector. The problem is that dermatophyte presence is often misdiagnosed.
"Until recently vets have had to rely on either single test kit, or for a full diagnosis, by sending a sample to laboratory where tests cost up to £20 and can take 14 days to complete.
"With the launch of ChroMyco Duo, we're giving practices the capability to test reliably, simply and cost-effectively for the first time."
For further information on ChroMyco Duo or Invicta, please contact the company on 01403 791313 or email them at mail@invictavet.com.
For decades, animal welfare and public health issues have been reported at a variety of animal establishments. The Animal Protection Agency says that inconsistent inspection methods and a lack of objective guidelines have contributed to a situation it describes as unacceptable.
The new report, ‘Guidelines for Inspection of Companion and Commercial Animal Establishments', which was part-funded by the APA and is published in Frontiers in Veterinary Science1, offers guidelines for animal husbandry (including invertebrates, fishes, amphibians, reptiles, mammals and birds) and inspection protocols for a variety of commercial and non-commercial establishments.
Space for animals, responsible handover, facility layout and human health and safety are among the issues detailed in the publication, which also offers a scoring tool.
The APA says the publication is believed to be the most objective information resource of its kind anywhere in the world. It is freely accessible to anyone, whether for formal governmental, professional managerial or private use.
Lead author and biologist Clifford Warwick said: "Clear, definitive and objective guidance for animal care and facility inspection has long been needed to enable responsible authorities to oversee animal health and welfare with confidence, and hopefully many will welcome and find helpful this new report."
Co-author and veterinary expert Mike Jessop MRCVS said: "Animal welfare and improved public health are the clear winners from a standardised inspection system that is applicable to all companion animal establishments. Moving to a more objective and evidenced system of inspection is long overdue. The same principles and protocols are readily adaptable to encompass inspection of any animal holding facility."
Animal Protection Agency Director Elaine Toland said: "Britain has been called a 'nation of animal lovers', and many want the best for their pets. But there is also a nation of 'animal traders and keepers' out there who often aim to provide the most 'cost effective' and therefore lowest possible standards of space, habitat and general care that they can get away with, and that mindset needs to change."
The Disciplinary Committee, chaired by Dr Martin Whiting, considered two charges against Mr Shah.
The first charge alleged that in June 2018 Mr Shah allowed a kitten to be anaesthetised for a castration without having first undertaken a clinical examination.
Then, having failed to locate a second testicle during the surgery, it was alleged that Mr Shah failed to contact the owner to inform her of this failure and to discuss the treatment options arising as a result, before ending his attempts at the castration.
The charge then alleged that Mr Shah failed to devise an adequate plan for the completion of the castration, failed to take adequate steps to ensure that the owner was fully informed of the details of the surgery, and failed to make adequate clinical notes in relation to the kitten.
The second charge alleged that, in relation to the conduct in charge one, Mr Shah failed to have adequate regard to previous advice and warnings from the RCVS about his conduct in relation to neutering surgery and related clinical note-keeping and communication with clients.
In particular, this related to a reprimand issued in September 2016 by the Disciplinary Committee following its finding of disgraceful conduct with regards to his discharge of a dog following castration in 2014, and advice issued to Mr Shah by letter of 21 March 2018 by the College’s Preliminary Investigation Committee with regards to circumstances surrounding canine spay surgery performed by him in 2016.
At the outset of the hearing Mr Shah denied all of the charges.
Nevertheless, the Committee found the following charge one sub-charges proved: that Mr Shah allowed the kitten to be anaesthetised without having first undertaken a clinical examination of the kitten and/or ensuring that they had undergone a clinical examination by another veterinary surgeon; that Mr Shah failed to devise an adequate plan for the completion of the castration, that he failed to take adequate steps to ensure that the owner was fully informed post-operatively of the details of the said surgery; and that he failed to make adequate clinical notes in relation to the findings of his examination under anaesthesia, his surgical approach, post-operative communication with the owners and his plan for completion of the castration.
The Committee also found all of charge two proved.
The Committee then went on to consider whether or not, in relation to the proved charges, Mr Shah’s conduct amounted to serious professional misconduct.
In considering the aggravating factors, the Committee took into account the risk of injury to an animal, the contravention of previous advice given by the College, lack of insight, and the previous adverse findings of the Disciplinary Committee and the Preliminary Investigation Committee.
With regards to mitigating factors, the Committee accepted that the conduct was not premeditated, that there was no financial gain and that, notwithstanding the contents of charge two, the first charge was a single and isolated incident.
Considering both the aggravating and mitigating factors, the Committee was satisfied that Mr Shah’s conduct fell far below the standard expected of a registered veterinary surgeon and consequently that it amounted to serious professional misconduct.
The Committee then considered what sanction to impose on Mr Shah. The Committee first considered lesser sanctions, including postponement with undertakings and a reprimand and warning. Neither would be sufficient to protect animals and the wider public interest and uphold proper standards because Mr Shah had already been given a reprimand and warning in 2016, which appeared, to the Committee, to have had no effect.
Speaking on behalf of the Committee, Dr Whiting said: "It is clear to the Committee that in this case, the respondent has failed to demonstrate any insight into the seriousness of his misconduct.
"In this case, the Committee considers that there is evidence of a harmful deep-seated personal attitude problem so far as the respondent is concerned. His pervasive denial of wrongdoing and lack of insight, in spite of the findings of this Committee, is of grave concern.
"The respondent’s persistent abdication of personal responsibility and accountability for anything that went wrong, coupled with his sustained blaming of the nursing staff with whom he worked, displays an attitude which is fundamentally incompatible with being a member of the veterinary profession.
"The Committee cannot be confident that there is no significant risk of repeat behaviour in the event that suspension was found to be the appropriate sanction and that the respondent is fit to practise after any period of suspension.
"This is particularly due to the fact that Mr Shah has failed to have adequate regard to previous advice and warnings from the RCVS, coupled with multiple previous adverse findings of the Disciplinary Committee and the Preliminary Investigation Committee. The Committee has reached this conclusion having regard to the seriousness of its findings in this hearing, and the previous advice and warning given to the respondent, none of which appears to have been recognised or heeded."
The Committee therefore concluded that the only sanction which reflects the seriousness of this case, in the light of the previous findings and advice given to the Mr Shah by the College, is to remove him from the Register.
The Committee’s full facts and findings can be found at www.rcvs.org.uk/disciplinary.
The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
The gilets, which normally cost $170, have three heating zones: one around the neck, one across the back of the shoulders and one which heats the pockets, all powered by a small battery.
VetSurgeon Editor Arlo Guthrie (pictured right) said: "As some members will know, I have a sideline reviewing gadgets and consumer tech on YouTube. Having reviewed the Ororo gilet, I bought a number of them for myself and my family, but thanks to a mix up by Amazon, I ended up with a spare men's XL size gilet (45-48 inch chest, 40-43 inch waist and 46-49 inch hip) .
"I'd like it to go to a good home, and I thought maybe a veterinary surgeon or nurse who now has to attend to clients in a frosty car park might be very glad of it.
"Of course, there are more women than men in the profession, so I'm going to offer one of the womens' vests too."
To win one of the gilets, watch the review here: https://www.youtube.com/watch?v=l84lRgEN1s4, then email: support@vetsurgeon.org with the answer to the following question:
On the medium heat setting, how long does the Ororo heated gilet stay warm?
First two correct answers out of the hat from those received by close of play next Wednesday (13th January) will get the gilets.
Arlo added: "Good luck, and a very happy New Year to you all. Let's hope we all get the vaccine soon.
"Oh, and if you enjoy the review, do subscribe on YouTube!"
Step 1: Clean with Oticare, a non-irritating, alcohol-free ceruminolytic ear cleaner formulated to keep ears hygienically clean and restore the normal microbiological balance of the ear canal. The product contains soothing essential oils and propylene glycol to moisturise the lining of the ear canal. It also contains a low concentration of lactic acid and salicylic acid.
Step 2: Treat with Aurimic (polymyxin B, miconazole and prednisolone acetate), which tackles the most common causes of otitis externa; e.g. Staphylococcus spp. and Malassezia. Animalcare says the proven synergistic effects of polymyxin B and miconazole1 allow the reduction of antibiotic concentration and help to minimise the probability of resistance.
Step 3: Prevent with new Oticurant, which Animalcare says is a completely new concept for maintaining healthy ears. Oticurant contains lactic acid to lower the pH, kaolin and lactose to absorb any additional moisture, and special sugars to prevent bacterial adherence to the skin in the ear canal. Oticurant is presented as an odourless mixture of fine powder in single dose sachets.
Tamsin Day, Veterinary Advisor at Animalcare, said: "This is a unique three step approach which we believe will give veterinary professionals more confidence in treating first line ear problems. The Super-earo’s represent a range of three products that together cover cleaning, treatment and prevention. Pet owners will find them easy to administer which will also help to keep these owners compliant to their treatment schedule."
For more information on the Super-earo’s contact your Animalcare representative or visit www.superearos.com
The Disciplinary Committee heard that Miss Oakes had signed a Greyhound Board of Great Britain (GBGB) Veterinary Surgeons Residential Kennel Inspection Form which indicated that there were 55 greyhounds in the kennel, when there were in fact more; that she had stated that the kennels were in an acceptable condition, when they were in fact not; and that she knew the form was inaccurate and/or was dishonest in relation to what she had indicated on the form.
The kennels in question, Rough Cottage, were owned by Louise Eccles and her husband, Rod Eccles. Mrs Eccles was licensed by GBGB as a trainer, allowing her to train and race greyhounds and making the kennels accountable to inspections by veterinary surgeons.
At the time of the form in question, Miss Oakes had been attending Rough Cottage for about a year-and-a-half on a monthly basis, up through August 2016. At that point, on or around 1 August 2016, Mrs Eccles had left Rough Cottage for personal reasons.
Miss Oakes subsequently visited the premises on 14 August 2016 along with Amanda Gething of Northern Greyhound Rescue, when she learned that rather than there being 55 dogs, there were more than 80.
On 16 August, she and Amanda Gething returned to Rough Cottage with Lucille Cavadino, from Lancky Dogs, a greyhound rescue organisation. They became aware of the existence of kennels on the premises that were not of acceptable standard, but Miss Oakes found that the dogs housed in these kennels were fit and healthy.
Miss Oakes also spoke to Mr Eccles around this time, and although he had plans to rehouse some of the dogs she was concerned that he might change his mind. Miss Oakes took the decision to complete and sign the kennel inspection form that Mr Eccles had handed to her, knowing that the details contained therein were incorrect. She stated that the reason that she did this was to appease Mr Eccles so that he would not hinder the plans to remove and rehouse the dogs. She admitted to the area GBGB Stipendiary Steward that she had signed the form and that it contained incorrect information.
At the beginning of the hearing Miss Oakes admitted all the charges except for the final one, namely that she had been dishonest about what she had indicated on the form. When she gave evidence during the hearing, however, she admitted that she had been dishonest and so all charges were found proved.
The Committee then turned to deciding whether these charges, having been found proven, would result in a finding of disgraceful conduct in a professional respect against Miss Oakes. The Committee considered her motives in signing the form were to try and safeguard animal welfare, but considered that she was misguided in how she chose to achieve that aim. The Committee, therefore, found that signing a form that is known to be misleading or inaccurate is in definite breach of the Code of Professional Conduct, and concluded that her conduct constituted disgraceful conduct in a professional respect.
When considering a suitable sanction, the Committee took into account a number of mitigating factors, including some 62 testimonials that were submitted in favour of Miss Oakes, and the fact that she believed she was acting in the best interests of the animals’ welfare.
Chitra Karve, Chair of the Disciplinary Committee, said: "So far as mitigating factors are concerned, the Committee is satisfied that the Respondent’s motivation for what she did was governed by her overwhelming wish to promote the health or welfare of the greyhounds at Rough Cottage.
"The Committee is satisfied that no actual harm or risk of harm to any animal occurred in this case. There was no financial gain to the Respondent and the Committee has been told that she charged no fee for her extensive efforts in organising or assisting with the removal and rehousing of the greyhounds from Rough Cottage.
"The Committee considers that this was a single and isolated incident and that the risks of similar behaviour being repeated in the future are low."
Chitra added: "The Committee has decided that it will be sufficient to protect the welfare of animals, to maintain public confidence in the profession and to declare and uphold proper standards of conduct, for the Respondent to be given a formal warning as to her future conduct."
Vets for Ukrainian Pets will cover the treatment costs of up to five dogs, cats, horses or other pet animals, up to 250 Euros per animal, for acute care and medication, rabies and other vaccinations as well as microchipping and medical examination required for safe passage through the EU.
The initiative is being funded by HSI, with support from Mars.
It is being run collaboration with Federation of Veterinarians in Europe and the Federation of European Companion Animal Veterinary Associations.
Reimbursements for participating veterinary surgeons will be available wherever the FECAVA has members, including in the United Kingdom, Germany, Italy, Romania and Poland, as well as Ukraine.
Ruud Tombrock, executive director of HSI/Europe, said: “In Europe’s biggest refugee crisis since WWII, millions of Ukrainians have had to take the decision to leave their country and flee the war.
"Along with a few possessions, many are also taking their pet animals, who they cherish as family members.
"The trauma of war as well as the stress of the evacuation journey, can make animals vulnerable to a variety of illnesses and so HSI’s Vets for Ukrainian Pets program aims to eliminate barriers to accessing veterinary care for the pets of refugees.
"It will provide a much-needed safety net for those families fleeing with their beloved pets so that at no point they feel compelled to leave their pets behind due to concerns about being able to care for them.”
Vets for Ukrainian Pets will run until 21st May 2022 and is open for all licensed veterinary clinics to apply throughout Europe, whether owned privately or as part of a corporate group.
Veterinary surgeons who want to join the program should visit apply.vetsforukraine.com.
Norbrook Laboratories Ltd has launched a new addition to the Loxicom range: Loxicom 0.5mg/ml Oral Suspension for Cats.
Offering alleviation from inflammation and pain, Loxicom Oral Suspension for Cats is billed by Norbrook as 'the new cost-effective treatment for chronic musculo-skeletal disorders in cats that is bio-equivalent to the pioneer.'
The Loxicom range now offers vet practices a choice between 5mg/ml Solution for Injection for Dogs and Cats, 1.5mg/ml Oral Suspension for Dogs and now 0.5mg/ml Oral Suspension for Cats.
Loxicom Oral Suspension for Cats is available in a clear 15ml bottle allowing veterinary surgeons and their clients to monitor product levels and re-order when necessary. The packaging also includes a graduated syringe in 0.5kg increments (from 0.5-10kg) which plugs securely into the bottle allowing accurate, mess-free administration.
Norbrook's small animal range also includes Carprieve, a range of carprofen tablets and injection and Noroclav, the amoxycillin / clavulanic acid range of tablets and injection.
SPVS has announced that Professor Noel Fitzpatrick will appear ‘In Conversation’ with Martin Whiting, lecturer in ethics at the RVC, at the SPVS/VPMA Congress at the Celtic Manor Resort on 29/30th January 2016.
Noel is both an inspirational and a controversial figure. Few would question that his orthopaedic and neurology work has been both brilliant and life saving. Anyone close to him will tell you he is a dedicated workaholic who believes passionately in the sanctity of life.
However, some would argue that programmes like the BBC’s Bionic Vet and Channel 4’s Super Vet may raise expectations among pet owners as to what the average vet practice can do. And then there's the question of just how far practitioners should go to save / prolong an animal's life. Just because you can, does it mean you should?
These are the areas that will be explored in this hour long ‘conversation’ in a format borrowed from literary festivals. There will be an opportunity for the audience to submit their questions from the floor.
For further details and to to book, visit www.spvs-vpma-events.co.uk or call 01453 872731.
Miss Panait faced the charge that on 3 April 2018, at Cardiff Magistrates’ Court, she was convicted of causing serious injury by dangerous driving for which she was sentenced to 10 months in prison, disqualified from driving for 41 months and ordered to pay a victim surcharge of £140.
At the start of the hearing Miss Panait admitted to the charge against her which related to an accident on 15 May 2017 in which, following an attempt to overtake a number of vehicles, she lost control of her car and collided with a vehicle on the other side of the road, causing serious injuries to herself and life-changing injuries to the other driver. The Committee subsequently found this charge to be proved.
The Committee then considered whether the charge found proved made her unfit to practise veterinary surgery.
In doing so, it took into account the fact that Miss Panait was convicted of a serious crime which resulted in serious harm to another and for which she received a custodial sentence.
The Committee decided that the criminal conviction and the custodial sentence fell far below the standard expected of a veterinary surgeon and therefore rendered her unfit to practise veterinary surgery.
In considering her sanction, the Committee heard directly from Miss Panait who attended the hearing having been released from prison on licence.
Stuart Drummond, chairing the Committee and speaking on its behalf, said: "After the submissions the respondent spoke directly to the Committee. She was understandably emotional and was remorseful and apologetic. She acknowledged that she had made a mistake and apologised for bringing the profession into disrepute…. To the Committee her sense of personal responsibility or shame was palpable."
The Committee also took into account other aggravating and mitigating factors in the case.
The Committee recognised that it was a serious offence with significant consequences for both the victim and Miss Panait but accepted it was a single isolated incident, that Miss Panait has made efforts to avoid repetition of the incident by undertaking further driving instruction and recognised that she had displayed full insight and remorse. Furthermore, it also considered the many testimonials from colleagues and clients and that she had received significant support from her employers.
Mr Drummond added: "The Committee came to the conclusion that this was one of those exceptionally unfortunate and sad cases where it is appropriate and proportionate to take no further action. The respondent has insight and is deeply remorseful and has accepted full responsibility for what has happened.
"In the circumstances of this case the Committee determined that the public interest has been met by the finding that the respondent’s conviction renders her unfit to practise. The Committee was of the view that to impose any sanction now would be disproportionate."
Paragon’s head of neurology, Massimo Mariscoli, says it will deliver better results for pets, improve the health and well-being of the surgeons using it, and improve the hospital’s ability to deal with complex spinal and brain surgeries.
Massimo, an EBVS and RCVS specialist in veterinary neurology said: “The operative microscope is an essential piece of equipment in the modern neurosurgical theatre.
“It delivers good magnification, good illumination without significant aberration or production of excessive heat and has a great internal stability which allows operational flexibility.
“There is also direct visual control of the instrumentation with the possibility to have magnifications up to 10 times with a good depth of field allowing a more natural three-dimensional vision.
“In addition, surgical microscopes allow multiple different magnifications while maintaining constant working distances which leads to excellent flexibility and versatility during surgical procedures.
“For example, low magnification is used during the drilling of the vertebral laminar or the skull and to ensure that the whole surgical field is clean before suturing the muscle layers.
“Higher magnification is used while dealing with delicate structures such as the spinal cord or brain.
“The higher magnification coupled with a good depth of view and stable three-dimensional vision also increases the security and safety when manipulating micro-surgical instruments near the nervous tissue.”
Massimo says that while the microscopes are not common in veterinary practices, he strongly believes they are an essential piece of equipment when dissecting close to the brain or spinal cord in small animals.
He also says that veterinary surgeons benefit from the technology: "The operative neurosurgical microscope is fixed to a self-levelling tripod, allowing multiple spatial configuration to ensure a perfect vision of the surgical field.
“This has a positive outcome on the health and well-being of the surgeons, with a 2013 study showing that, for nearly 85% of the time spent operating, surgeons have symmetrical, non-neutral, head-neck posture.”
For more information, visit www.paragonreferrals.co.uk.
The RCVS Disciplinary Committee has directed that the name of a Berkshire-based veterinary surgeon, previously convicted of four offences under the Animal Welfare Act 2006, should be removed from the RCVS Register of Veterinary Surgeons.
Dr Ohene-Gyan was convicted at Reading Magistrates Court on 13 June 2012 of offences involving causing unnecessary suffering to three dogs and a cat that he had treated whilst working at Woosehill Vets, Wokingham, between February and October 2011. These offences related to failing to provide adequate or appropriate veterinary care or treatment, or failure to investigate and address an animal's poor condition. He was sentenced to 21 weeks' imprisonment concurrently for each offence.
Dr Ohene-Gyan did not attend the one-day Disciplinary Committee hearing and was not represented, although College records showed that he was aware of the dates of the hearing, and had had opportunity to apply for an adjournment. In the absence of any known good reason for Dr Ohene-Gyan's non-attendance, the Committee concluded that it was in the interests of justice that the hearing go ahead.
In considering whether the Respondent's convictions made him unfit to practise as a veterinary surgeon, the Committee depended on the findings of the District Judge and the remarks she had made when sentencing. "I found as a matter of fact that some of your actions were taken simply to run up a bill for the owners of pets," she had said. "You were in a position of special responsibility, trusted by the owners of the animals to treat them appropriately and to alleviate their suffering. You ignored advice from staff. Several animals were affected by your cruel disregard of their welfare. Some of the cruelty arose due to your incompetence. You have demonstrated that you are not fit to be trusted with the care of animals."
The Disciplinary Committee Chairman, Professor Peter Lees, speaking on behalf of the Committee, said: "The Respondent's actions, motivated by financial gain, caused serious actual injury to the four animals over a prolonged period of time. Clients are entitled to expect that veterinary surgeons will treat animals in their care humanely and with respect, and make animal welfare their first priority. The Committee considers that the care described in the District Judge's findings demonstrated a total disregard for the professional responsibilities of a veterinary surgeon."
The Committee concluded that the removal of Dr Ohene-Gyan's name from the Register was the only appropriate and proportionate sanction in this case in order to protect the welfare of animals, maintain public confidence in the profession and uphold proper standards of conduct, and it directed the Registrar to do so.
If you are speaking at or hosting a small animal CPD event in 2019, please email details to press@vetsurgeon.org for it to be considered for addition to this list.
This list includes events from CPD Solutions, Improve International, the Veterinary Poisons Information Service and the Small Animal Medicine Society.
Esteban Gonzalez joins the practice in Southfields, Laindon, from Ars Veterinaria in Barcelona, one of the leading veterinary hospitals in Spain.
Esteban (pictured right with VRCC Clinical Director, Henry L’Eplattenier) graduated at the Autonomous University of Barcelona (UAB) in 2002. After working as a veterinary emergency in Paris for a year, he did an 18-month rotating internship of at the UAB. He then worked for three years in a veterinary hospital as a soft tissue and emergency surgeon.
In January 2009, he began a three-year residency in small animal surgery in Neuilly-sur-Seine, France, under the supervision of Dr Jean-Francois Bardet, one of France’s leading veterinary surgeons.
As part of his training, he made several visits to the US with graduates of American surgery, as well as specialists in oncology, anaesthesia and emergency medicine.
During his residency he published several articles and gave presentations at national and international conferences.
Esteban graduated as a European specialist in surgery and a diplomate of the European College of Veterinary Surgeons (ECVS) in February 2014. He then worked as a specialist surgeon in the UK for two years until last year when he joined Ars Veterinaria.
VRCC says his is the first of a number of planned appointments which will result in two veterinary surgeons appointed to each of the practice’s eight specialities.
The business is also undergoing a rebranding and rebuilding operation that will see the practice renamed as Southfields.
Operations manager Daniel Hogan said: "The recruitment plan will ensure we continue to offer state-of-the-art veterinary medicine across the board — in oncology, soft tissue surgery, orthopaedics, internal medicine, feline medicine, anaesthesia, diagnostic imaging, neurology and cardiology."
Clinical director at VRCC Henry L’Eplattenier said: "Esteban is a hugely experienced and well-respected specialist, who we are delighted has chosen to join the team here.
"Having his kind of expertise adds to our already considerable skill-sets and is part of a major drive to attract some of the best people in the industry to VRCC."
For more information, visit www.vrcc.co.uk.
1243 farmers took part in the survey, which was held in partnership with the National Beef Association, British Dairying magazine, the relevant farming unions and the four eradication programmes.
Matt Yarnall from Boehringer said: "Reliance on veterinary input for this decision shows how valuable client discussion and guidance is. And further interrogation of the data shows other areas of BVD control where veterinary input could be extremely valuable.
"Too many producers are still holding onto PI animals in the hope they can be reared successfully and too many are making basic mistakes when it comes to herd biosecurity.
"The survey data revealed that 43% of farmers in Wales have identified a PI, but it is hugely concerning that almost half (42%) of these producers would not cull them immediately; these animals will go on to spread virus throughout the herd."
In Northern Ireland, 26 individual producers said they have kept a PI. "However, 20 had to be put down before reaching adulthood or had to be treated for other health conditions," said Matt. "Even in Scotland, with its well-established scheme, a small percentage of farmers claim they would isolate a PI and try to rear to slaughter and it was exactly the same in England."
Similarly, when it came down to the definition of a closed herd, Boehringer reports that there was significant lack of understanding about what this actually means.
Matt said: "Of the 62% of English producers that state they are closed herds, 2% rear calves away, 19% bring bulls in, 2% buy in heifers or cows and 1% purchase fattening stock.
"Obviously, this means they are not truly a closed herd and supports previous years when 23% and 24% of ‘closed herd’ producers in 2018 and 2017 respectively also brought bulls onto the farm.
"Add to this that 10% of these herds do not currently vaccinate so will not be protected against the BVD virus, and it is clear to see how vulnerable they are."
In Wales, 56% of herds were classified as closed, yet 12% still brought bulls on to the farm. Likewise in Northern Ireland, 60% of farms classified their herds as closed but 20% brought bulls on to the unit. The vast majority of Scottish herds also claimed to be closed, yet there were still inconsistencies around buying policy and biosecurity.
Matt said: "A certain lack of awareness about both the BVD Stamp it Out initiative and Gwaredu BVD schemes (43% English and 27% of Welsh producers respectively claimed to have no knowledge of these programmes) could actually be a positive for vets. It could be the perfect opportunity to engage in proactive conversations with clients, covering issues such as testing, PI removal and biosecurity."
Furosoral contains furosemide and is indicated for the treatment of hydrothorax, hydropericardium, ascites and oedema, particularly in animals where these conditions are associated with cardiac insufficiency and renal dysfunction.
Furosoral replaces Dechra’s previous diuretic treatment, Frusedale.
It is available in both 10 mg and 40 mg double-divisable tablets.
The recommended daily starting dose for cats and dogs is 2.5 mg per kg of body weight.
Dechra says careful weighing is essential to ensure accurate dosing, but that the dosage can be doubled initially for severe or particularly resistant cases and adjusted to the lowest clinically effective dose for maintenance therapy if required.
Dechra companion animal brand manager, Charlotte Hill, said: “Furosoral offers a flexible treatment solution where dosage can be adjusted, depending on the needs of the patient and the underlying causes, to give vets more options for treating cats and dogs with fluid retention.
“To ensure it is as appealing to pet owners as it is to veterinary professionals, Furosoral is available in our innovative Smart Tab format, giving owners confidence that they are giving their dog or cat the right dosage and aiding compliance, leading to better outcomes for the animal.”
Furosoral 10 mg and 40 mg tablets are available in blister packs of 100 tablets for quick and easy dispensing. Divided tablets can be stored in the blister pack for up to three days, ensuring no waste.
https://www.dechra.co.uk/products/dog/prescription#/search=furosoral/.
Intervet/Schering-Plough Animal Health is now supplying Cepravin dry cow antibiotic treatment in a new 'flexi-cap' tube which offers two ways of infusing the product into the cows' teats.
According to the company, the new cap is easier to remove and can be quickly flicked off with a fingernail, whilst the shorter, thinner nozzle option may reduce the chances of damaging the teat canal and teat end. Farmers can be assured that administering Cepravin dry cow therapy with a shorter, thinner nozzle still delivers the antibiotic where it needs to be, and at the correct dose.
Jennifer O'Connor, vet adviser at Intervet/Schering-Plough Animal Health said: "The teat canal is a vital barrier to infection. A gentle infusion technique is essential to avoid causing damage, reducing its ability to close properly and form a keratin plug to help keep infection out. We are delighted to be introducing an innovative development for one of the UK's most widely used dry cow tubes."